MNMD
Mind Medicine (MindMed) Inc.NASDAQHealthcare$20.69+0.44%ClosedMarket Cap: $1.56B
As of 2026-04-04
Valuation
P/E (TTM)
—
PEG
—
P/B
5.49
P/S
0.00
EV/EBITDA
-10.47
DCF Value
$2.84
FCF Yield
-6.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-84.4%
ROA
-41.8%
ROIC
-44.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $-47.6M | $-50.4M | $-0.50 | — |
| FY 2025 | $0.00 | NaN% | $-166.3M | $-183.8M | $-2.06 | — |
| Q3 2025 | $0.00 | NaN% | $-45.7M | $-67.3M | $-0.78 | — |
| Q2 2025 | $0.00 | NaN% | $-40.9M | $-42.7M | $-0.50 | — |
| Q1 2025 | $0.00 | NaN% | $-32.2M | $-23.3M | $-0.27 | — |
| Q4 2024 | $0.00 | NaN% | $-32.5M | $-34.7M | $-0.41 | — |
| FY 2024 | $0.00 | -Infinity% | $-103.9M | $-108.7M | $-0.15 | — |
| Q3 2024 | $0.00 | NaN% | $-24.8M | $-13.7M | $-0.17 | — |
| Q2 2024 | $0.00 | NaN% | $-24.5M | $-5.9M | $-0.08 | — |
| Q1 2024 | $0.00 | -Infinity% | $-22.2M | $-54.4M | $-1.14 | — |
| Q4 2023 | $0.00 | NaN% | $-22.2M | $-23.9M | $-0.59 | — |
| FY 2023 | $0.00 | -Infinity% | $-93.9M | $-95.7M | $-2.44 | — |